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The role of microbiota in regulating the immune system has
gained much importance in recent years, since it plays a cru-
cial role in disease development and prevention. The human
body harbors 100 trillion commensal microbes, exceeding
the number of host cells by more than 10-fold, with a huge
amount of genetic information, that is, 100-fold more genes
than the human genome. With this enormous pool of genetic
information, the microbiota may inﬂuence human life at
many levels including host immunity and its regulation.
The immune mechanisms elucidating the molecular interac-
tions between the microbiota and host immune system com-
ponents have come up with new and interesting therapeutic
approaches. Recent studies focusing on the interactions
between microbiota and the host immune system have
revealed the fundamental importance of the microbiome in
shaping host immune responses, aﬀecting susceptibility
against immune-mediated and infectious diseases.
A total of 15 manuscripts were received for this special
issue, and 9 manuscripts have been accepted for publication
after rigorous rounds of review process. This issue provides
a glimpse of some of the ongoing eﬀorts in the area of
immune regulation by microbiota and management of the
human health. For example, some featured papers provide
useful information regarding the role of microbiota in altered
immune mechanisms in human diseases such as rheumatoid
arthritis, multiple sclerosis, erythema nodosum, connective
tissue diseases and vasculitides, and allergic asthma.
One of the interesting research articles presented by A.
Fusco et al. explores the role of β-defensins in protecting
the intestinal epithelium against S. typhimurium and their
interaction with the gut microbiota. In particular, the exper-
iments of coinfection with S. typhimurium and probiotic E.
faecium showed that, in the presence of E. faecium, Salmo-
nella infection caused a much less intense inﬂammatory
response. Overall, the ﬁndings of this study propose that
antimicrobial peptides (AMPs) could be considered, in the
future, a new class of therapeutics since they are able to
induce lesser resistance and have a selective antimicrobial
activity to protect the host without the need for the immune
system memory.
The research article presented by L. M. Rocha-Ramírez
et al. reveals the innate immune mechanisms generated due
to probiotic Lactobacillus strains. In particular, the study
demonstrates that strains of Lactobacillus exert early immu-
nostimulatory eﬀects that may be directly linked to the initial
inﬂammation of the response of human macrophages. The
study further proposes that the eﬀect of these probiotics as
potential immunomodulators in immunocompromised
hosts could be evaluated.
The research article presented by C. F. Michael et al. pro-
vides interesting insights into repair of epithelial damage in
asthmatic airways by using prebiotic mannan (SC-MN)
derived from S. cerevisiae. Unlike the mannan derived
from bacteria, SC-MN does not stimulate Th17 inﬂamma-
tory cytokines and the study reports that SC-MN showed
an increased expression and activation of Krüppel-like fac-
tors (KLFs) 4 and 5, key transcription factors for epithelial
cell diﬀerentiation, survival, and proliferation. Since anti-
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inﬂammatory therapy alone has not been shown to halt dis-
ease progression in asthma, the study proposes a therapy that
could promote epithelial repair and provide adjunctive
therapeutic beneﬁt for asthma. In this line, another
research article by D. B. Lew et al. demonstrated the ben-
eﬁcial eﬀects of SC-MN on allergic asthma mouse models.
In particular, the study showed that the antismooth muscle
(ASM) hyperplasia/hypertrophy in the mouse model due
to allergen challenge can be preventable with SC-MN
treatment. The study further concludes that the prebiotic
mannose receptor blocker SC-MN is a promising agent
that can render dual beneﬁts in asthma, that is, anti-
inﬂammatory and ASM remodeling at the level of both large
and small airways. Another research article by O. Ozbagcivan
et al. presents a retrospective descriptive study which exam-
ines the frequency and type of infections in the etiology of
erythema nodosum (EN). The study identiﬁed, besides
Streptococci, many other microbes including the ones living
on and inside the human body to be of importance in the
etiology of EN.
The current issue also involves interesting review articles.
G. Horta-Baas et al. present a review article which provides
some evidence linking intestinal dysbiosis with the autoim-
mune mechanisms involved in the development of rheuma-
toid arthritis (RA). The article reviewed various studies that
have evaluated the inﬂuence of gut microﬂora on the etio-
pathogenesis of RA as well as RA severity. The article pro-
poses that a speciﬁc or systematic manipulation of certain
intestinal microbiota associated with host diseases could
change therapeutic strategies in subjects with RA.
Further, G. Ranucci et al. present a review article on the
role of early life intestine microbiota in the lungs’ health in
children. In particular, the review article discusses the recent
development in gut-lung axis research, with emphasis on the
eﬀects of targeting microbiota of infants and children at a risk
of or with progressive lung diseases. The article proposes that
such knowledge could open new possibilities for therapeutic
interventions in modifying the progression of chronic lung
diseases as well as preventing its onset in population at risk.
The recent advances in sequencing technologies allowed
for an unprecedented growth in the information about the
diversity of bacterial species providing a valuable informa-
tion how this diversity is associated with human health and
disease. In this special issue, R. Talotta et al. review the latest
information about the role of human microbiota in the path-
ogenesis of connective tissue diseases (CTDs) and vasculiti-
des. This is a highly understudied ﬁeld, and the authors
discuss the potential links between dysbiosis and pathogene-
sis of inﬂammatory arthritides, such as systemic lupus
erythematosus, systemic sclerosis, Sjӧgren’s syndrome, and
Behçet’s disease. A more targeted evaluation of the impact
of gut microﬂora on the pathophysiology of multiple sclero-
sis (MS) has been discussed by M. Adamczyk-Sowa et al. The
results showed that the MS patients’ intestinal microﬂora is
characterized by moderate dysbiosis in combination with
the protective eﬀect of some Bacteroides metabolites against
demyelinating in animal models, which suggests the exis-
tence of a very close interaction between the intestinal
mucosa and the brain.
Thus, many previous and current reports suggest that
there is a captivating relationship between microbiota and
immune system. Although a few mechanisms of immune
regulation by microbiota have been described, the exact role
of microbiota in various diseases is still unknown. However,
interventional studies are needed to elucidate such functional
aspects of microbiota or their product’s role in immune reg-
ulatory mechanisms. This knowledge will be of importance
in order to optimize clinical studies and gain deeper mecha-
nistic insights.
In summary, this special issue covers many important
aspects of microbiota role in immune regulation and human
health. We hope that this special issue can provide valuable
information to investigators in the ﬁeld of microbiota and
immune regulation and also give the readers a sense of the
advancements made in this ﬁeld.
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